Physician profile
Alan Feit
NPI 1245224716
$1,915.86
in general payments reported to CMS, 2019-2025
21 companies · $588 in 2025
The $588 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $189 · 2021: $202 · 2022: $55.63 · 2023: $186 · 2024: $220 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $994.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $258.02 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $256.63 | 2019-2025 | Amvuttra |
| Astrazeneca Pharmaceuticals Lp | $245.38 | 2019-2025 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $161.99 | 2021-2025 | Camzyos |
| Pfizer INC. | $121.55 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.05 | 2019-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $106.10 | 2022-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $101.40 | 2022-2025 | Verquvo |
| Abbott Laboratories | $98.67 | 2019-2025 | Cardiomems |
| Abiomed | $96.78 | 2019-2024 | Impella |
| Bridgebio Pharma, INC. | $80.98 | 2025 | Attruby |
| Medtronic, INC. | $48.68 | 2023 | Linq II, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $40.73 | 2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $37.03 | 2023 | Rotapro |
| Shockwave Medical, INC | $30.84 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $27.65 | 2025 | Uptravi, Opsumit |
| Ge Healthcare | $26.15 | 2019 | |
| Philips North America LLC | $23.66 | 2019 | |
| Amgen INC. | $21.15 | 2021 | |
| Astellas Pharma US INC | $14.41 | 2020 | |
| Z-Medica, LLC | $6.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Feit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.